Immunosuppressive Drugs
National · Effective Jan 1, 2026
1 active Medicare policy lists J7520, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Jan 1, 2026
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J7520 |
|---|---|---|
| Hyftor (sirolimus gel) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Hyftor (sirolimus) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J7520 |
|---|---|---|
| Sirolimus protein-bound particles for injectable suspension (e.g., Fyarro) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7520 |
|---|---|---|
| Sirolimus protein-bound particles for injectable suspension (albumin-bound) (Fyarro) | Mar 2, 2022 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7520 |
|---|---|---|
| Sirolimus Protein-Bound Particles (Fyarro), Topical Gel, (Hyftor); CP.PHAR.574 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J7520 |
|---|---|---|
| 00813 sirolimus topical gel (Hyftor) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |